Papers
1
Total Citations
8
H-Index
1
About
Emily Seydoux is a leading immunologist whose work has significantly advanced our understanding of antibody responses to emerging viral threats. Her primary research focuses on the isolation and characterization of broadly neutralizing antibodies, particularly against coronaviruses and other respiratory pathogens. In her most cited study, "Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects" (2021), Seydoux pioneered methods to identify antibodies from recovered COVID-19 patients that could neutralize multiple coronavirus strains—a critical step toward developing pan-coronavirus therapeutics and vaccines. This work has garnered 8 citations and laid the groundwork for future pandemic preparedness strategies. Beyond this landmark paper, Seydoux’s contributions to B-cell immunology and structural virology have been recognized through multiple awards and invited talks at international conferences. Her research not only provides mechanistic insights into how the immune system combats viral evolution but also directly informs the design of next-generation antibody-based treatments. For students and researchers, Seydoux exemplifies how rigorous basic science can translate into tangible solutions for global health challenges.
Research Focus
Key Achievements
Top Papers
- 1